Prescription Drugs: Abuse Education and Diversion Control Efforts

$130.00

John J. Phillips (Editor)
Wallace O. Penny (Editor)

Series: Substance Abuse Assessment, Interventions and Treatment
BISAC: MED036000

The Center for Disease Control and Prevention has declared that the United States is in the midst of an epidemic of prescription drug overdose deaths, with deaths associated to prescription pain relievers of particular concern. To address this issue, federal agencies are raising awareness by educating prescribers and the general public. This book examines the recent national trends in prescription pain reliever abuse and misuse; describes how the federal agencies are educating prescribers; assesses the extent to which federal agencies follow key practices for developing public education efforts; and identifies educational efforts that use similar strategies and assesses how agencies coordinate those efforts. (Imprint: Nova)

Clear

Details

Table of Contents

Preface

Prescription Pain Reliever Abuse: Agencies Have Begun Coordinating Education Efforts, but Need to Assess Effectiveness
(GAO)

Prescription Drug Control: DEA Has Enhanced Efforts to Combat Diversion, but Could Better Assess and Report Program Results
(GAO)

Statement of Michele M. Leonhart, Administrator, Drug Enforcement Administration. Hearing on “Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion and Fraud”

Statement of John L. Eadie, Director, Prescription Monitoring Program Center of Excellence, Brandeis University. Hearing on “Responding to the Prescription Drug Epidemic: Strategies for Reducing Abuse, Misuse, Diversion and Fraud”

Index

Additional information

Binding

,